HCW Biologics Inc. Profile Avatar - Palmy Investing

HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injecta…

Biotechnology
US, Miramar [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of HCWB's Analysis
CIK: 1828673 CUSIP: 40423R105 ISIN: US40423R1059 LEI: - UEI: -
Secondary Listings
HCWB has no secondary listings inside our databases.